Studies of enzymatic degradation of luteinizing hormone-releasing hormone by different tissues  by Kochman, K. et al.
Volume 50, number 2 FEBS LETTERS February 1975 
STUDIES OF ENZYMATIC DEGRADATION OF LUTEINIZING HORMONE- 
RELEASING HORMONE BY DIFFERENT TISSUES 
K. KOCHMAN*, B. KERDELHUl?, U. ZOR** and M. JUTISZ 
Laboratoire des Hormones Polypeptidiques, CNRS, 91190, Gif-sur- Yvette, France 
Received 25 November 1974 
1. Introduction 
The isolation and structure identification of luteini- 
zing hormone-releasing hormone (LH-RH) [ 1,2] togeth- 
er with its synthesis had led to the use of this hormone 
for many biochemical and physiological studies [3]. 
In the course of our research on the in vitro biosynthe- 
sis of LH-RH in the rat hypothalamus, we observed 
that this hormone undergoes a rapid inactivation as 
determined by radioimmunoassay. Subsequently, the 
examination of the incubates by thin layer chromato- 
graphy allowed us to observe the presence of several 
degradation products. 
There are some reports on inactivation of LH-RH 
by plasma [4], brain tissue and hypothalamus [5-71. 
Lipmann has also recently reported the degradation 
of another hypothalamic hormone TRH by hypothalam- 
ic tissue [8]. 
The aim of this work was to measure the inactiva- 
tion of LH-RH by homogenates of median eminence, 
of hypothalamic tissue without median eminence, of 
pituitary gland and of brain cortex and to find inhibi- 
tor(s) preventing its inactivation. 
2. Materials and methods 
2.1. Reagents 
Synthetic LH-RH was provided by Drs R. 0. 
* On leave from the Institute of Animal Physiology and 
Nutrition, Polish Academy of Sciences, Jablonna near 
Warsaw, Poland. 
** On leave from the Department of Biodynamics, The 
Weizmann Institute of Science, Rehovot, Israel. 
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Studer and D. Gillessen (Hoffmann-La Roche, Basel, 
Switzerland). Kallikrein inhibitors (KI): two batches 
of Trasylol (Bayer A. G., Frankfurt, Germany) were 
used, SK/T22/3, 5100 KIU/mg and GOS 746/31, 
5700 KIU/mg. These two products were provided by 
Dr Y. Koch, Rehovot, Israel. One batch of Zymofren, 
another Kallikrein inhibitor (JMi 1297, 1032 KIU/ml) 
was obtained from SociCte des Usines Chimiques 
‘RhBne-Poulenc’ (Paris, France). 
2.2. Tissue preparations and analytical methods 
Normal male rats (Wistar, laboratory strain) weighing 
300 to 3.50 g were used. The animals were killed under 
light ether anaesthesia, tissues were rapidly collected 
in ice-cold 0.01 M Tris-HCI buffer, pH 7.6, contain- 
ing 50 mM KC1 t 12 mM MgClz (Tris buffer) 8 mgjml 
and homogenized in an all glass homogenizer, immers- 
ed in crushed ice. Starting from this point, two types 
of procedures were employed. 
(a) For analysis by thin-layer chromatography, 
homogenates of the region of median eminence (4 mg) 
and of anterior pituitary glands were filtered through 
Sartorius membranes in a cold room in order to re- 
move endogenous amino acids and peptides. 25 ~1 of 
filtered homogenate were mixed with 25 1.11 of LH-RH 
(50 pg) solution in Tris buffer. 
Incubation was performed at 30°C for one or two 
hours. Reaction was stopped by adding 75 ~1 of abso- 
lute ethanol. Unincubated tubes served as controls 
(zero time). After centrifugation, 5 ~1 aliquots of su- 
pernatant were applied to thin-layer cellulose plates. 
Chromatograms were developed in the following sol- 
vent: n-butanol-acetic acid-water (75: 10:25). Spots 
were detected by spraying with 0.25% ninhydrin in 
acetone or with Pauly reagent. 
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(b) For radioimmunoassay of LH-RI-I, homogen- 
ates of median eminence, entire hypothalamus without 
median eminence (40 mg) anterior pituitary (5-6 mg) 
and brain cortex, were centrifuged at 1000 g for 10 
min to remove cell debris. Only supernatants were ta- 
ken for incubation (30°C, 30 and 60 min). Incubation 
tubes contained: 0.5 ml of supernatant (equivalent to 
4 mg of tissue), 0.5 ml of Tris buffer (with or without 
KI), 0.1 ml of LH-RI-I solution (5 ng) in Tris buffer. 
KI was added to some tubes in amounts of 250 c(g 
per tube. 
Radioimmunological assay (RIA) of LH-RH was 
performed according to the method developed in our 
laboratory [9,10]. Results were expressed as percent- 
age of zero time incubation. 
3. Results 
Fig.1 shows the results of measurements of LH- 
RH activity in the incubation media using RIA. The 
most important inactivation of LH-RI-I occurred in 
the presence of homogenates of brain cortex (100% 
inactivation in 30 min), the inactivation was less 
for hypothalamus without median eminence and 
pituitary gland and still less for median eminence. 
In the presence of Trasylol SK/T22/3, LH-RH in- 
activation was in all cases partially but noticeably 
diminished. This batch of Trasylol inhibited LH- 
RI-I inactivation at the highest level in brain cortex 
incubates (about 90% of recovery); inhibition was 
less for hypothalamus and median eminence incu- 
bates (respectively 75 and 65% of recovery) and 
still less for pituitary incubates (about 41% of re- 
covery). 
Figs.2 and 3 show thin-layer chromatograms, re- 
vealed with ninhydrin, of incubates of median emi- 
nence and pituitary with LH-RH in absence and in 
presence of two batches of Trasylol, SK/T2213 and 
GOS 746/3 1, respectively. Intact LH-RH is ninhy- 
drin positive spot, while incubated with LH-RH 
for 60 and 120 min the same homogenate showed 
- Hypothslamus - Brain Cortex 
-Median EminenCe h Pituitary 
+d Hypothalamus + KI c -A Brain Cortex + KI 
c+- +Median Eminence + KI LA Pituitary + KI 
TIME 
Fig. 1. Effect of incubation of LH-RH with homogenates of rat median eminence, of hypothalamus without median eminence, 
of pituitary and brain cortex. Equivalents of 4 mg of tissue in 1 .l ml of Tris buffer were incubated at 30°C with 5 ng of LH-RH 
in the presence or absence of a Kallikrein inhibitor (Kl, Trasylol batch No. SK/T22/3). 40 and 160 ~1 aliquots of the incubation 
media were essayed using RIA-and reqults were exDressed as percentage of LH-RH content. Vertical bars represent standard of 
error of the mean. 
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Fig.2. Thin-layer chromatography of LH-RH incubated for 1 or 2 hr with homogenates of rat median eminence (ME). Trasylol 
SK/T22/3 (KI,) or Trasylol GOS 746/31 (KI,) was added to some tubes. Chromatogram was revealed with ninhydrin (see text 
for details). 1. LH-RH; 2. ME zero time; 3. ME incubated for 1 hr; 4. ME incubated for 2 hr; 5. LH-RH + ME zero time: 6. 
LH-RH + ME incubated for 1 hr; 7. LH-RH + ME incubated for 2 hr; 8. LH-RH + ME + KI, time zero; 9. LH-RH + ME + 
KI, incubated for 1 hr; 10. LH-RH + ME + KI, incubated for 2 hr; Il. LH-RH +ME + KI, zero time; 12. LH-RH + ME + KI, 
incubated for 1 hr; 13. LH-RH + ME + KI, incubated for 2 hr. 
Fig. 3 
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appearance of three new ninhydrin positive spots 
deriving from LH-RH. Trasylol SK/T22/3 partial- 
ly prevented degradation of LH-RH while Trasylol 
GOS 746/3 1 and Zymofren were without effect. 
LH-RH incubated with pituitary homogenates 
also showed several ninhydrin positive spots. Inten- 
sity of these spots was greatly diminished in the 
presence of Trasylol SK/T22/3. Again Trasylol 
GOS 746/31 and Zymofren were without action. 
Very similar results were obtained when chroma- 
tograms were sprayed with Pauly reagent. After in- 
cubation of LH-RH with homogenates of median 
eminence and pituitary gland two spots appeared 
in addition to that of LH-RH which was also po- 
sitive with Pauly reagent. 
4. Discussion 
The rat hypothalamus has been already shown 
to contain peptidases capable of inactivating oxy- 
tocin [ 11,121, TRH [8] and LH-RH [5,6] . Grif- 
fith and Hooper [6] suggested that the same enz- 
ymes in rat hypothalamus which inactivate oxytocin 
may also inactivate LH-RH. Oxytocin is inactivated 
by cleavage of C-terminal glycinamide and leucyl- 
glycinamide. It is possible that in LH-RH the same 
bonds are split as in oxytocin. Pyroglutamic acid 
also could be split from LH-RH, since pyrrolidone- 
carboxylyl peptidase which specifically cleave py- 
roglutamic acid from NH2 -terminal position of cer- 
tain peptides, was isolated from bovine pituitary 
gland and other tissues [ 121. 
Radioimmunoassay of LH-RH activity in the 
incubation media containing homogenates of differ- 
ent tissues appears to be an adequate method for 
measurements of enzymatic inactivation of the de- 
capeptide. This method is highly specific of LH-RH 
as was shown in a study of many structural analo- 
gues of this decapeptide [14,15]. Only LH-RH 
possessing an intact structure gave a 100% response. 
Peptides shorter than LH-RH had no activity in 
our RIA system. 
In the present work the RIA method combined 
with thin layer chromatography method was chosen. 
By the RIA method we were able to show a rapid 
inactivation of LH-RH during incubation with ho- 
mogenates and supernatants of all examined tissues. 
Our results suggest hat LH-RH is split at least in- 
to three peptidic fragments because three ninhydrln 
positive spots appeared on the plates. Inhibition of 
LH-RH degradation by only one batch of Trasylol 
suggests that only this preparation contained substances 
capable of inhibiting enzymes present in tissue homo- 
genates and responsible for the partial hydrolysis 
of LH-RH. It is possible that inhibition was due 
not to the Kallikrein inhibitor itself, but to some 
impurities present in one commercial preparation 
of this substance (SK/T22/3). 
Results obtained in the present work are in agree- 
ment with other publications [5,6] in which the in- 
activation of LH-RH was reported. Our observation 
that Trasylol may inhibit proteases involved in the 
degradation of LH-RH is also in agreement with a 
report by Koch et al. [7]. 
In short our results and those reported by others 
show that it is possible, at least partially, to prevent 
degradation of LH-RH by enzymes present in ho- 
mogenates from median eminence and thus to use 
this method for in vitro study of the biosynthesis 
of LH-RH. 
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